NO20082396L - Fremgangsmater for behandling av mave-tarmkanalinfeksjoner med tigecyclin - Google Patents

Fremgangsmater for behandling av mave-tarmkanalinfeksjoner med tigecyclin

Info

Publication number
NO20082396L
NO20082396L NO20082396A NO20082396A NO20082396L NO 20082396 L NO20082396 L NO 20082396L NO 20082396 A NO20082396 A NO 20082396A NO 20082396 A NO20082396 A NO 20082396A NO 20082396 L NO20082396 L NO 20082396L
Authority
NO
Norway
Prior art keywords
tigecycline
methods
gastrointestinal tract
tract infections
treating gastrointestinal
Prior art date
Application number
NO20082396A
Other languages
English (en)
Inventor
Syed Muzafar Shah
Mahdi B Fawzi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20082396L publication Critical patent/NO20082396L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det er her beskrevet fremgangsmåter for behandling av minst én bakterieinfeksjon, så som infeksjoner i nedre gastrointestinaltraktus, omfattende oral administrering av et farmasøytisk preparat omfattende tigecyklin. Preparatene kan ha faste eller flytende former, så som løsninger, dispersjoner eller faste former omfattende tigecyklin med minst ett enterisk belegg.
NO20082396A 2005-12-22 2008-05-27 Fremgangsmater for behandling av mave-tarmkanalinfeksjoner med tigecyclin NO20082396L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75316105P 2005-12-22 2005-12-22
PCT/US2006/048617 WO2007075792A1 (en) 2005-12-22 2006-12-20 Methods of treating gastrointestinal tract infections with tigecycline

Publications (1)

Publication Number Publication Date
NO20082396L true NO20082396L (no) 2008-08-26

Family

ID=37963595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082396A NO20082396L (no) 2005-12-22 2008-05-27 Fremgangsmater for behandling av mave-tarmkanalinfeksjoner med tigecyclin

Country Status (15)

Country Link
US (1) US20070243244A1 (no)
EP (1) EP1962860A1 (no)
JP (1) JP2009521456A (no)
KR (1) KR20080085184A (no)
CN (1) CN101340917A (no)
AU (1) AU2006331685A1 (no)
BR (1) BRPI0620430A2 (no)
CA (1) CA2631632A1 (no)
CR (1) CR10023A (no)
EC (1) ECSP088634A (no)
GT (1) GT200800115A (no)
IL (1) IL191598A0 (no)
NO (1) NO20082396L (no)
RU (1) RU2008121238A (no)
WO (1) WO2007075792A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1877064A2 (en) * 2005-05-06 2008-01-16 Wyeth Delivery of tigecycline in the presence of heparin
AU2009249180A1 (en) * 2008-05-19 2009-11-26 Burnham Institute For Medical Research Intestinal Alkaline Phosphatase modulators and uses thereof
CN102970992B (zh) * 2010-05-12 2016-07-06 莱姆派克斯制药公司 四环素组合物
CN103356662B (zh) * 2012-03-27 2015-11-25 浙江医药股份有限公司新昌制药厂 注射用替加环素组合物及其制备方法
CN103263400B (zh) * 2013-01-16 2014-12-17 内蒙古金河动物药业有限公司 一种金霉素微囊制剂及其制备方法
CA2904327C (en) * 2013-03-05 2021-06-08 Enteris Biopharma, Inc. Pharmaceuticals for oral delivery
CA2973099C (en) 2015-01-12 2021-09-14 Enteris Biopharma, Inc. Solid oral dosage forms
SG11201808246SA (en) * 2016-03-24 2018-10-30 Paratek Pharm Innc Methods for treating and preventing c. difficile infection
CN111166729A (zh) * 2020-03-19 2020-05-19 珠海赛隆药业股份有限公司 一种口服的替加环素肠溶微球及其制备方法
CN112843071A (zh) * 2020-09-08 2021-05-28 天津国际生物医药联合研究院 土霉素或者替加环素在抗分枝杆菌感染中的潜在应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026248A (en) * 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5281628A (en) * 1991-10-04 1994-01-25 American Cyanamid Company 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) * 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
SG47520A1 (en) * 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
MX9603508A (es) * 1994-02-17 1997-03-29 Pfizer Analogos de la doxiciclina.
US5675030A (en) * 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
US5567693A (en) * 1994-12-13 1996-10-22 American Cyanamid Company Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US6063775A (en) * 1997-04-29 2000-05-16 Berman; Charles L. Retardation of metalloproteinase incidental to HIV and/or AIDS
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6015803A (en) * 1998-05-04 2000-01-18 Wirostko; Emil Antibiotic treatment of age-related macular degeneration
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
US20040131628A1 (en) * 2000-03-08 2004-07-08 Bratzler Robert L. Nucleic acids for the treatment of disorders associated with microorganisms
CZ20023581A3 (cs) * 2000-03-31 2003-04-16 Trustees Of Tufts College Tetracyklinové sloučeniny substituované v poloze 7 a 9 karbamátem, močovinou, thiomočovinou, thiokarbamátem a heteroaryl-aminem
CZ303702B6 (cs) * 2000-07-07 2013-03-20 Trustees Of Tufts College Minocyklinové slouceniny
EP2289871A1 (en) * 2000-07-07 2011-03-02 Paratek Pharmaceuticals, Inc. 7-substituted tetracycline compounds
EP2301913A1 (en) * 2001-03-13 2011-03-30 Paratek Pharmaceuticals, Inc. 7,9-Substituted tetracycline compounds
US6841546B2 (en) * 2001-03-14 2005-01-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
EP2301550A1 (en) * 2001-07-13 2011-03-30 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
EP2311799A1 (en) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
WO2004006850A2 (en) * 2002-07-12 2004-01-22 Paratek Pharmaceuticals, Inc 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
TW200500071A (en) * 2002-08-29 2005-01-01 Activbiotics Inc Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US20050148553A1 (en) * 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Also Published As

Publication number Publication date
CR10023A (es) 2008-08-21
CA2631632A1 (en) 2007-07-05
RU2008121238A (ru) 2010-01-27
AU2006331685A1 (en) 2007-07-05
GT200800115A (es) 2009-01-16
US20070243244A1 (en) 2007-10-18
CN101340917A (zh) 2009-01-07
KR20080085184A (ko) 2008-09-23
EP1962860A1 (en) 2008-09-03
BRPI0620430A2 (pt) 2011-11-08
IL191598A0 (en) 2009-08-03
ECSP088634A (es) 2008-08-29
WO2007075792A1 (en) 2007-07-05
JP2009521456A (ja) 2009-06-04

Similar Documents

Publication Publication Date Title
NO20082396L (no) Fremgangsmater for behandling av mave-tarmkanalinfeksjoner med tigecyclin
WO2008154642A3 (en) Antibacterial agents
BRPI0809977A8 (pt) Uso de um composto, compostos e composição farmacêutica que o contém
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
WO2008092006A3 (en) Antimicrobial compositions
WO2004062601A3 (en) Antibacterial agents
WO2012031298A3 (en) Ethynylbenzene derivatives
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
TW200640908A (en) Chemical compounds
WO2006120563A3 (en) Antibacterial agents
WO2008115281A3 (en) Compounds for treating viral infections
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
WO2005089733A3 (en) Anti-adhesive compounds to prevent and treat bacterial infections
WO2008017381A8 (de) Arylaminoaryl-alkyl-substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
NO20082547L (no) Orale formuleringer omfattende tigecycline
EP3216798A3 (en) Ketolide compounds
BRPI0905687A2 (pt) "composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto"
CR20230100A (es) Compuestos fosfolípidos y usos de los mismos
EA201001859A1 (ru) Гетероциклические производные мочевины и способы их применеия
EA201001858A1 (ru) Гетероциклические производные мочевины для лечения бактериальных инфекций
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
AR062217A1 (es) Derivados de 4- trimetilamonio-3- aminobutirato y 4- trimetilfosfonio-3-aminobutirato como inhibidores de la cpt
BR112022006608A2 (pt) Inibidores orais do fator d do complemento

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application